"Flight For A Cure" Golf Classic

National Aviation Academy (NAA) is a proud supporter of Juvenile Diabetes Research Foundation (JDRF). Over the past few years, NAA has raised funds by participating in sponsored walks and helping facilitate various charity events. We are proud to present the second annual “Flight For A Cure” Golf Classic to be held in conjunction with our January Career Fair and Grand Open House in early 2013. With the addition of “Flight For A Cure” NAA hopes to partner with several national and local organizations to raise over $40,000 in 2013 Teams of four players will be hitting the links at one of Tampa Bay’s most prestigious golf courses. The day will also include a chance to meet Tampa Bay Ray outfielder Sam Fuld who is diagnosed with Type-1 Diabetes. Please mark your calendars and join us at this FUNdraising event

Honorary Chairman Sam Fuld

Samuel Babson “Sam” Fuld, was born November 20, 1981 and is a professional baseball player with the Tampa Bay Rays. Despite being diagnosed with Diabetes at age 10, Sam persevered and refused to let the disease slow down his baseball career. He hit .600 in his last 2 high school baseball seasons and earned the distinction from Baseball America as one of the top 20 players in the nation. He pursued his academic and baseball career at Stanford where he graduated with a degree in finance while starring for the Stanford Cardinal baseball team that made 3 straight trips to the College World Series. Sam established a CWS record for career hits and finished his Stanford career with school records for runs scored and was a 2-time All-American. Learn More

JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is the largest charitable supporter of T1D research. The goal of JDRF is to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.

Since its founding in 1970, JDRF has awarded more than $1.5 billion to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. Past JDRF research efforts have helped to significantly improve the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered.